Divalproex SA NA (24HR) Tablets   3

Background
The solicitation is issued by the Department of Veterans Affairs (VA) and the Department of Defense (DoD) for the acquisition of pharmaceutical products through their respective Pharmaceutical Prime Vendor (PPV) Programs. The purpose is to establish a supply source that will provide drugs listed in the schedule for purchase through the PPV Programs. The contract effective date, implementation period, and ordering period are specified in the solicitation. The contractor will receive payments from the PPV programs instead of directly from the government.

Work Details
The specific products to be supplied include Divalproex Sodium (NA) Sustained Action (SA)(24 hr) Tablets. The solicitation requires offerors to submit prices for line items 1, 2, 3, and 4 for the base year and each of the four option years. Offered prices must include a 0.50% Cost Recovery Fee. Offerors must also list an 11-digit National Drug Code (NDC) number for each offered drug that is unique to the offeror's company. The schedule of supplies includes quantities, package sizes, unit prices, and total amounts for each line item over the base year and option years.

Period of Performance
The contract will be effective on the date the government signs the SF-1449 and notifies the offeror of award. The implementation period will begin on the contract effective date and end at the start of the ordering period. The base year ordering period will be in effect for one year.

Place of Performance
The products will be delivered to various facilities including all VA facilities, all DoD Pharmaceutical Prime Vendor Program participants, Indian Health Service facilities, Bureau of Prisons facilities, Captain James A. Lovell Federal Health Care Center, and State Veteran Homes.